Seville's Universal DX raises 62 million euros for early cancer detection

Universal DX, based in Seville, has raised 62 million euros. The company develops tests that detect cancer from a routine blood sample, combining biotechnology, occupational health and artificial intelligence. The funding will speed up time to market and strengthen southern Spain's position in biotech.

Read the full article in Russian